UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 91

Sortiert nach

The Effect of Platelet-Rich Plasma on the Intra-Articular Microenvironment in Knee Osteoarthritis

International journal of molecular sciences, 2021-05, Vol.22 (11), p.5492

2021

Link zum Volltext

Verfügbarkeit prüfen

Th2 Cytokines (Interleukin-5 and -9) Polymorphism Affects the Response to Anti-TNF Treatment in Polish Patients with Ankylosing Spondylitis

International journal of molecular sciences, 2022-10, Vol.23 (21), p.13177

2022

Link zum Volltext

Verfügbarkeit prüfen

Polymorphisms within Genes Coding for IL-17A and F and Their Receptor as Clinical Hallmarks in Ankylosing Spondylitis

Mediators of inflammation, 2021-10, Vol.2021, p.3125922-9

2021

Link zum Volltext

Verfügbarkeit prüfen

IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients

Frontiers in immunology, 2021-06, Vol.12, p.631603-631603

2021

Link zum Volltext

Verfügbarkeit prüfen

Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study

Journal of bone and mineral research, 2024-04, Vol.39 (3), p.202-210

2024

Link zum Volltext

Verfügbarkeit prüfen

The Influence of Body Mass Index on Growth Factor Composition in the Platelet-Rich Plasma in Patients with Knee Osteoarthritis

International journal of environmental research and public health, 2022-12, Vol.20 (1), p.40

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis

The pharmacogenomics journal, 2020-12, Vol.20 (6), p.760-769

2020

Link zum Volltext

Verfügbarkeit prüfen

Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis

Immunologic research, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

The changing role of ultrasonography examination in patients with rheumatoid arthritis in light of recent studies

Reumatologia, 2020, Vol.58 (3), p.155-161

2020

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with quality of life in systemic sclerosis: a cross-sectional study

Quality of life research, 2019-12, Vol.28 (12), p.3347-3354

2019

Link zum Volltext

Verfügbarkeit prüfen

Tocilizumab as a first-line biologic treatment in rheumatoid arthritis patients – the impact of concomitant methotrexate treatment and Rheumatic Disease Comorbidity Index on the clinical response – results from the multicenter observational ACT-POL study

Reumatologia, 2022-01, Vol.60 (2), p.92-100

2022

Link zum Volltext

Verfügbarkeit prüfen

Brief Report: Safety and Immunogenicity of Rituximab Biosimilar GP 2013 After Switch From Reference Rituximab in Patients With Active Rheumatoid Arthritis

Arthritis care & research (2010), 2019-01, Vol.71 (1), p.88-94

2019

Link zum Volltext

Verfügbarkeit prüfen

Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III, Randomized, Double-Blind ADMYRA Study

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2020-12, Vol.34 (6), p.809-823

2020

Link zum Volltext

Verfügbarkeit prüfen

Polymorphisms within the RANK and RANKL Encoding Genes in Patients with Rheumatoid Arthritis: Association with Disease Progression and Effectiveness of the Biological Treatment

Archivum Immunologiae et Therapiae Experimentalis, 2020-08, Vol.68 (4), p.24-24, Article 24

2020

Link zum Volltext

Verfügbarkeit prüfen

Deep dive into achieving the therapeutic target: results from a prospective, 6‑month, observational study nested in routine rheumatoid arthritis care

Polskie archiwum medycyny wewne̦trznej, 2022-09, Vol.132 (9)

2022

Link zum Volltext

Verfügbarkeit prüfen

Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis

Genes, 2018-01, Vol.9 (2), p.64

2018

Link zum Volltext

Verfügbarkeit prüfen

Intra-Articular Injection of Platelet-Rich Plasma Is More Effective than Hyaluronic Acid or Steroid Injection in the Treatment of Mild to Moderate Knee Osteoarthritis: A Prospective, Randomized, Triple-Parallel Clinical Trial

Biomedicines, 2022-04, Vol.10 (5), p.991

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study

Advances in therapy, 2024, Vol.41 (1), p.315-330

2024

Link zum Volltext

Verfügbarkeit prüfen

The role of ultrasonography in the diagnostic criteria for rheumatoid arthritis and monitoring its therapeutic efficacy

Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2018-09, Vol.27 (9), p.1303-1307

2018

Link zum Volltext

Verfügbarkeit prüfen

Influence of CD94 and NKG2A variants on susceptibility to rheumatoid arthritis and efficacy of anti-TNF treatment

Joint, bone, spine : revue du rhumatisme, 2016-01, Vol.83 (1), p.75-79

2016

Link zum Volltext

Verfügbarkeit prüfen

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis

The New England journal of medicine, 2021-04, Vol.384 (13), p.1227-1239

2021

Link zum Volltext

Verfügbarkeit prüfen

The rheumatoid hand in the light of fluorescence: a diagnostic technique of the future?

Reumatologia, 2019, Vol.57 (1), p.45-49

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacoeconomic evaluation of costs of rheumatoid arthritis therapy with selected biological treatment

Reumatologia, 2018, Vol.56 (6), p.340-345

2018

Link zum Volltext

Verfügbarkeit prüfen

Baseline new bone formation does not predict bone loss in ankylosing spondylitis as assessed by quantitative computed tomography (QCT): 10-year follow-up

BMC musculoskeletal disorders, 2011-05, Vol.12 (1), p.121-121, Article 121

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(89)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(47)
Science & Technology
(47)
Humans
(40)
Rheumatoid Arthritis
(38)
Female
(28)
Rheumatology
(28)
Male
(26)
Middle Aged
(24)
Adult
(21)
Patients
(21)
Arthritis, Rheumatoid - Drug Therapy
(19)
Treatment Outcome
(19)
Antirheumatic Agents - Therapeutic Use
(14)
Double-Blind Method
(14)
Antirheumatic Agents - Adverse Effects
(12)
Aged
(11)
Monoclonal Antibodies
(11)
Arthritis
(10)
Clinical Trials
(10)
Immunology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Effect of Platelet-Rich Plasma on the Intra-Articular Microenvironment in Knee Osteoarthritis

Th2 Cytokines (Interleukin-5 and -9) Polymorphism Affects the Response to Anti-TNF Treatment in Polish Patients with Ankylosing Spondylitis

Polymorphisms within Genes Coding for IL-17A and F and Their Receptor as Clinical Hallmarks in Ankylosing Spondylitis

IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients

Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study

The Influence of Body Mass Index on Growth Factor Composition in the Platelet-Rich Plasma in Patients with Knee Osteoarthritis

Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis

Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis

The changing role of ultrasonography examination in patients with rheumatoid arthritis in light of recent studies

Factors associated with quality of life in systemic sclerosis: a cross-sectional study

Tocilizumab as a first-line biologic treatment in rheumatoid arthritis patients – the impact of concomitant methotrexate treatment and Rheumatic Disease Comorbidity Index on the clinical response – results from the multicenter observational ACT-POL study

Brief Report: Safety and Immunogenicity of Rituximab Biosimilar GP 2013 After Switch From Reference Rituximab in Patients With Active Rheumatoid Arthritis

Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III, Randomized, Double-Blind ADMYRA Study

Polymorphisms within the RANK and RANKL Encoding Genes in Patients with Rheumatoid Arthritis: Association with Disease Progression and Effectiveness of the Biological Treatment

Deep dive into achieving the therapeutic target: results from a prospective, 6‑month, observational study nested in routine rheumatoid arthritis care

Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis

Intra-Articular Injection of Platelet-Rich Plasma Is More Effective than Hyaluronic Acid or Steroid Injection in the Treatment of Mild to Moderate Knee Osteoarthritis: A Prospective, Randomized, Triple-Parallel Clinical Trial

Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study

The role of ultrasonography in the diagnostic criteria for rheumatoid arthritis and monitoring its therapeutic efficacy

Influence of CD94 and NKG2A variants on susceptibility to rheumatoid arthritis and efficacy of anti-TNF treatment

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis

The rheumatoid hand in the light of fluorescence: a diagnostic technique of the future?

Pharmacoeconomic evaluation of costs of rheumatoid arthritis therapy with selected biological treatment

Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trial

Baseline new bone formation does not predict bone loss in ankylosing spondylitis as assessed by quantitative computed tomography (QCT): 10-year follow-up

Suchergebnisse filtern